IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Can Sitagliptin be used in combination with basal insulin?
Yes, Sitagliptin can be used with basal insulin. This combination often leads to improved blood sugar control with a reduced risk of hypoglycemia and weight gain.
Yes, Sitagliptin can be used with basal insulin. This combination often leads to improved blood sugar control with a reduced risk of hypoglycemia and weight gain.
See lessHow does Sitagliptin compare to GLP-1 receptor agonists in managing blood glucose?
Sitagliptin, a DPP-4 inhibitor, increases GLP-1 levels subtly, aiding stable blood glucose control with minimal hypoglycemia risk and weight gain. GLP-1 receptor agonists have stronger effects, reducing glucose, promoting weight loss, but may cause gastrointestinal issues and are injectable.
Sitagliptin, a DPP-4 inhibitor, increases GLP-1 levels subtly, aiding stable blood glucose control with minimal hypoglycemia risk and weight gain. GLP-1 receptor agonists have stronger effects, reducing glucose, promoting weight loss, but may cause gastrointestinal issues and are injectable.
See lessWhat is the recommended dose of Sitagliptin for newly diagnosed patients?
The standard dose of Sitagliptin for type 2 diabetes is 100 mg once daily. Dosing may be adjusted based on kidney function, with reductions to 50 mg or 25 mg daily if necessary.
The standard dose of Sitagliptin for type 2 diabetes is 100 mg once daily. Dosing may be adjusted based on kidney function, with reductions to 50 mg or 25 mg daily if necessary.
See lessHow does Sitagliptin improve glycemic control in patients with insulin resistance?
Sitagliptin enhances insulin secretion and reduces glucagon levels, improving glycemic control but does not directly affect glucose uptake in peripheral tissues.
Sitagliptin enhances insulin secretion and reduces glucagon levels, improving glycemic control but does not directly affect glucose uptake in peripheral tissues.
See lessWhat are the long-term benefits of Sitagliptin in diabetes management?
1. Sitagliptin has proven effective in preserving beta-cell function over time, reducing the progression of diabetes and decreasing the need for insulin therapy. 2. Long-term benefits of Sitagliptin include its ability to moderate blood sugar levels, which helps prevent serious diabetic complicationRead more
1. Sitagliptin has proven effective in preserving beta-cell function over time, reducing the progression of diabetes and decreasing the need for insulin therapy.
2. Long-term benefits of Sitagliptin include its ability to moderate blood sugar levels, which helps prevent serious diabetic complications such as neuropathy and retinopathy.
3. Sitagliptin helps in maintaining glucose levels and has a low risk of hypoglycemia, supporting sustained beta-cell health and function, crucial for long-term diabetes management.
See lessHow does Sitagliptin impact insulin secretion after meals?
Sitagliptin enhances insulin release post-meal by inhibiting DPP-4, which increases incretin levels, reducing postprandial glucose spikes in diabetics.
Sitagliptin enhances insulin release post-meal by inhibiting DPP-4, which increases incretin levels, reducing postprandial glucose spikes in diabetics.
See lessWhat are the common side effects of Sitagliptin?
Common side effects of Sitagliptin include headaches, sore throat, and runny nose. Managing these involves hydration, rest, and over-the-counter pain relievers. Monitor for severe reactions like pancreatitis.
Common side effects of Sitagliptin include headaches, sore throat, and runny nose. Managing these involves hydration, rest, and over-the-counter pain relievers. Monitor for severe reactions like pancreatitis.
See lessHow does Sitagliptin affect glucose metabolism in the pancreas?
Sitagliptin, a DPP-4 inhibitor, enhances glucagon-like peptide-1 (GLP-1) levels, boosting insulin synthesis and release, and reducing glucagon secretion when glucose levels are high.
Sitagliptin, a DPP-4 inhibitor, enhances glucagon-like peptide-1 (GLP-1) levels, boosting insulin synthesis and release, and reducing glucagon secretion when glucose levels are high.
See lessCan Sitagliptin be used as a monotherapy for type 2 diabetes?
Yes, Sitagliptin can be used as a monotherapy for type 2 diabetes. It effectively manages blood glucose levels but is less effective at reducing A1C compared to some other drugs.Sitagliptin, as a monotherapy, effectively controls blood sugar in type 2 diabetes patients and has a low risk of causingRead more
Yes, Sitagliptin can be used as a monotherapy for type 2 diabetes. It effectively manages blood glucose levels but is less effective at reducing A1C compared to some other drugs.
Sitagliptin, as a monotherapy, effectively controls blood sugar in type 2 diabetes patients and has a low risk of causing hypoglycemia.
Using Sitagliptin alone for type 2 diabetes can help control glucose levels; however, it might not address all aspects of diabetes management such as weight control.
See lessWhat are the common indications for Sitagliptin therapy?
Sitagliptin is indicated for type 2 diabetes to improve blood sugar control when diet and exercise are inadequate. It's most effective in adults without kidney issues.
Sitagliptin is indicated for type 2 diabetes to improve blood sugar control when diet and exercise are inadequate. It’s most effective in adults without kidney issues.
See less